Search Results
88 257 262 Earls, F.: Prevalence of the metabolic syndrome defined by the International Diabetes Federation Among Adults in the U
–2497. Zimmet, P., Alberti, G., Shaw, J.: A new IDF worldwide definition of the metabolic syndrome: the rationale and the results. Diabet. Voice, 2005, 50 , 31–33. Shaw J. A new IDF
–1536 (2007) Ahmed LA, Schirmer H, Berntsen GK, Fønnebø V, Joakimsen RM: Features of the metabolic syndrome and the risk of non-vertebral fractures: The Tromsø study. Osteoporos. Int. 17, 426–432 (2006) Joakimsen R
1414 1431 Editorial: The metabolic syndrome. Br. Med. J., 2003, 327 , 61–62. Grundy, S. M., Brewer, H. B., Cleeman, J. I
people with metabolic syndrome. Diabetes Care, 2007, 30 , 1219–1225. Sullivan L. M. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people
62 32 37 McEvoy, J. P., Meyer, J. M., Goff, D. C. és mtsai: Prevalence of the metabolic syndrome in patients with schizophrenia
Introduction Metabolic syndrome (MetS) represents a cluster of risk factors, including hypertension, dyslipidemia, elevated plasma glucose, and central obesity ( 7 , 25 ), with a prevalence of 20%–25% in adults ( 7 ). MetS
2004 4 442 448 Groop, L.: Genetics of the metabolic syndrome. Br. J. Nutr., 2000, 83 , S39–S48
Cowey, S., Hardy, R. W.: The metabolic syndrome A: High-risk state for cancer? Am. J. Pathol., 2006, 169 , 1505–1522. Hardy R. W. The metabolic syndrome A: High-risk state for
2001 285 2486 2497 Alberti, K. G. M. M., Zimmet, P., Shaw, J.: The metabolic syndrome – a new worldwide
